Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease
Summary
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease.
Description
An overtube and implant delivery mechanism is endoscopically guided to the gastro-oesophageal junction. Suction is applied to pull a fold of the oesophageal wall into the overtube. Saline is injected into this fold to create a space within the submucosa, and one or more hydrogel prostheses are implanted. The prostheses absorb water and expand to create a fold in the oesophageal wall bulking the oesophagus and preventing gastro-oesophageal reflux.
OPCS code:
G44.1 Fibreoptic endoscopic insertion of prosthesis into upper gastrointestinal tract
Includes: Endoscopic insertion of expanding metal stent into upper gastrointestinal tract
O11.1 Gastro-oesophageal junction
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
Details
Surgical procedures
Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland
British Society of Gastroenterology
Contact details:
(for general enquiries or comments)
(for procedure specific enquiries or comments)
ip@nice.org.uk
Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA
